Trilogy International : TIL appendix 3B notification of share issue

Appendix 38

Rule 2.7,3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities and agreement

Information ordocuments not available nowmust be given to ASX as soonas available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5Amended 01/o7/98, 01/09/99, 01/o7/oo, 30/09/01, n/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

f RILOGY INTERNATIONAL LTD

ABN

We (the entity) give ASX the following information.

Part 1 ·All issues

You must complete the relevant sections (attach sheets ifthere is not enough space).

1+Class of +securities issued or to IOrdinary Shares be issued

'--

37,500

2 Number of +securities issued or to be issued (if known) or maximum number which may be issued

Issues of 37,500 fully paid ordinary shares on exercise of options issued under the Trilogy International Limited Share Option Plan exercise price NZ$0.85 per option. Exercised 14th August 2017

3 Principal terms of the

+securities (e.g. if options,

exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if

+convertible securities, the conversion price and dates for conversion)

+See chapter 19for defined terms.

Appendix 3B Page 1

Yes

1. Do the +securities rank equally in all respects from the+issue date with an existing +class of quoted +securities?

   If the additional +securities do not rank equally, please state:

   • the date from which they do

   • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

   • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

     NZ$0.85 in relation to 37,500 share options exercised

2. Issue price or consideration

   Exercise of share options

3. Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

No

6a Is the entity an +eligible entity that has obtained security holder approval under rule 7.IA.?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

6bThe date the security holder Iresolution under rule 7.iA was passed

6c Number of +securities issued I

without security holder approval

under rule 7.1'--

+See chapter 19for defined terms. Appendix 3B Page 2

6d Number of +securities issued I

with security holder approval

under rule 7.IA .

6e Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

6f Number of +securities issued

under an exception in rule 7.2

6g If+securities issued under rule 7.IA., was issue price at least 75% of 15 day VWAP as calculated under rule 7.IA.3? Include the

+issue date and both values. Include the source of the VWAP calculation.

6h If+securities were issued under rule 7.IA for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

6i Calculate the entity's remaining issue capacity under rule 7.1and rule 7.IA - complete Annexure 1and release to ASX Market Announcements

37,500 shares14th August2017

7 +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Number	+Class
72,746,630	Ordinary Shares

Cross reference: item 33 of Appendix 3B.

8 Number and +class of all

+securities quoted on ASX ( includingthe +securities in section 2if applicable)

+See chapter 19for defined terms.

Appendix 3B Page 3

Number

+class

200,000 unlisted options exercisable at $0.60, which are scheduled to vest in 3 equal tranches on each of 10 March 2018, and 2019 and expiring on 10 April 2020,and 2021, respectively 572,500 unlisted options exercisable at $0.85 held by staff. 77,500 of these options vested on 31 March 2016 and remain to be exercised by 10 April 2018. 135,000 of these options vested on 31 March 2017 and remain to be exercised by 10 April 2019. 180,000 of these options are scheduled to vest on each of 31 March 2018 and 2019, which expire on, 2020, and 2021, respectively.

9 Number and +class of all

+securities not quoted on ASX

( including the +securities in section 2if applicable)

Same as existing Ordinary Shares

10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Part 2 ·Pro rata issue N/A

n Is securityholder approval required?

12 Is the issue renounceable or non­ renounceable?

13Ratio in which the +securitieswill be offered

14 +classof +securitiesto which the offer relates

15 +Record date to determine entitlements

+See chapter 19for defined terms. Appendix 38 Page 4